vs
Healthpeak Properties（DOC）与EPAM Systems（EPAM）财务数据对比。点击上方公司名可切换其他公司
EPAM Systems的季度营收约是Healthpeak Properties的2.0倍（$1.4B vs $719.4M），Healthpeak Properties净利率更高（73.2% vs 7.8%，领先65.4%），EPAM Systems同比增速更快（12.8% vs 3.1%），Healthpeak Properties自由现金流更多（$357.0M vs $268.1M），过去两年EPAM Systems的营收复合增速更高（9.9% vs 8.9%）
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
EPAM Systems是总部位于美国宾夕法尼亚州纽敦的企业，核心业务涵盖软件工程服务、数字平台研发、数字产品设计三大板块，同时是MACH联盟的创始成员，在全球数字化服务赛道拥有深厚的技术积累与行业认可度。
DOC vs EPAM — 直观对比
营收规模更大
EPAM
是对方的2.0倍
$719.4M
营收增速更快
EPAM
高出9.7%
3.1%
净利率更高
DOC
高出65.4%
7.8%
自由现金流更多
DOC
多$88.9M
$268.1M
两年增速更快
EPAM
近两年复合增速
8.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $719.4M | $1.4B |
| 净利润 | $114.0M | $109.4M |
| 毛利率 | — | 30.1% |
| 营业利润率 | 17.4% | 10.6% |
| 净利率 | 73.2% | 7.8% |
| 营收同比 | 3.1% | 12.8% |
| 净利润同比 | 2406.4% | 5.9% |
| 每股收益（稀释后） | $0.16 | $1.97 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCEPAM
| Q4 25 | $719.4M | $1.4B | ||
| Q3 25 | $705.9M | $1.4B | ||
| Q2 25 | $694.3M | $1.4B | ||
| Q1 25 | $702.9M | $1.3B | ||
| Q4 24 | $698.0M | $1.2B | ||
| Q3 24 | $700.4M | $1.2B | ||
| Q2 24 | $695.5M | $1.1B | ||
| Q1 24 | $606.6M | $1.2B |
净利润DOCEPAM
| Q4 25 | $114.0M | $109.4M | ||
| Q3 25 | $-117.1M | $106.8M | ||
| Q2 25 | $31.7M | $88.0M | ||
| Q1 25 | $42.8M | $73.5M | ||
| Q4 24 | $4.5M | $103.3M | ||
| Q3 24 | $85.9M | $136.3M | ||
| Q2 24 | $146.0M | $98.6M | ||
| Q1 24 | $6.7M | $116.2M |
毛利率DOCEPAM
| Q4 25 | — | 30.1% | ||
| Q3 25 | 58.6% | 29.5% | ||
| Q2 25 | 60.2% | 28.8% | ||
| Q1 25 | 61.1% | 26.9% | ||
| Q4 24 | 60.3% | 30.4% | ||
| Q3 24 | 60.0% | 34.6% | ||
| Q2 24 | 60.6% | 29.3% | ||
| Q1 24 | 59.8% | 28.4% |
营业利润率DOCEPAM
| Q4 25 | 17.4% | 10.6% | ||
| Q3 25 | 9.2% | 10.4% | ||
| Q2 25 | 5.7% | 9.3% | ||
| Q1 25 | 7.7% | 7.6% | ||
| Q4 24 | -2.2% | 10.9% | ||
| Q3 24 | 14.1% | 15.2% | ||
| Q2 24 | 22.3% | 10.5% | ||
| Q1 24 | 3.7% | 9.5% |
净利率DOCEPAM
| Q4 25 | 73.2% | 7.8% | ||
| Q3 25 | -16.6% | 7.7% | ||
| Q2 25 | 4.6% | 6.5% | ||
| Q1 25 | 6.1% | 5.6% | ||
| Q4 24 | 0.7% | 8.3% | ||
| Q3 24 | 12.3% | 11.7% | ||
| Q2 24 | 21.0% | 8.6% | ||
| Q1 24 | 1.1% | 10.0% |
每股收益（稀释后）DOCEPAM
| Q4 25 | $0.16 | $1.97 | ||
| Q3 25 | $-0.17 | $1.91 | ||
| Q2 25 | $0.05 | $1.56 | ||
| Q1 25 | $0.06 | $1.28 | ||
| Q4 24 | $0.02 | $1.80 | ||
| Q3 24 | $0.12 | $2.37 | ||
| Q2 24 | $0.21 | $1.70 | ||
| Q1 24 | $0.01 | $1.97 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $467.5M | $1.3B |
| 总债务越低越好 | $9.8B | — |
| 股东权益账面价值 | $7.5B | $3.7B |
| 总资产 | $20.3B | $4.9B |
| 负债/权益比越低杠杆越低 | 1.31× | — |
8季度趋势，按日历期对齐
现金及短期投资DOCEPAM
| Q4 25 | $467.5M | $1.3B | ||
| Q3 25 | $91.0M | $1.2B | ||
| Q2 25 | $89.4M | $1.0B | ||
| Q1 25 | $70.6M | $1.2B | ||
| Q4 24 | $119.8M | $1.3B | ||
| Q3 24 | $180.4M | $2.1B | ||
| Q2 24 | $106.9M | $1.8B | ||
| Q1 24 | $101.8M | $2.0B |
总债务DOCEPAM
| Q4 25 | $9.8B | — | ||
| Q3 25 | $9.1B | — | ||
| Q2 25 | $9.0B | — | ||
| Q1 25 | $8.9B | — | ||
| Q4 24 | $8.7B | — | ||
| Q3 24 | $8.6B | — | ||
| Q2 24 | $8.6B | — | ||
| Q1 24 | $8.8B | — |
股东权益DOCEPAM
| Q4 25 | $7.5B | $3.7B | ||
| Q3 25 | $7.6B | $3.7B | ||
| Q2 25 | $7.9B | $3.7B | ||
| Q1 25 | $8.2B | $3.6B | ||
| Q4 24 | $8.4B | $3.6B | ||
| Q3 24 | $8.6B | $3.6B | ||
| Q2 24 | $8.8B | $3.4B | ||
| Q1 24 | $8.9B | $3.5B |
总资产DOCEPAM
| Q4 25 | $20.3B | $4.9B | ||
| Q3 25 | $19.6B | $4.8B | ||
| Q2 25 | $19.8B | $4.7B | ||
| Q1 25 | $19.8B | $4.7B | ||
| Q4 24 | $19.9B | $4.8B | ||
| Q3 24 | $20.0B | $4.5B | ||
| Q2 24 | $20.2B | $4.2B | ||
| Q1 24 | $20.5B | $4.4B |
负债/权益比DOCEPAM
| Q4 25 | 1.31× | — | ||
| Q3 25 | 1.20× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.04× | — | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 0.98× | — | ||
| Q1 24 | 0.99× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3B | $282.9M |
| 自由现金流经营现金流 - 资本支出 | $357.0M | $268.1M |
| 自由现金流率自由现金流/营收 | 49.6% | 19.0% |
| 资本支出强度资本支出/营收 | 124.4% | 1.1% |
| 现金转化率经营现金流/净利润 | 10.99× | 2.59× |
| 过去12个月自由现金流最近4个季度 | — | $612.7M |
8季度趋势，按日历期对齐
经营现金流DOCEPAM
| Q4 25 | $1.3B | $282.9M | ||
| Q3 25 | $315.0M | $294.7M | ||
| Q2 25 | $363.5M | $53.2M | ||
| Q1 25 | $279.4M | $24.2M | ||
| Q4 24 | $1.1B | $130.3M | ||
| Q3 24 | $318.2M | $242.0M | ||
| Q2 24 | $316.2M | $57.0M | ||
| Q1 24 | $152.6M | $129.9M |
自由现金流DOCEPAM
| Q4 25 | $357.0M | $268.1M | ||
| Q3 25 | — | $286.4M | ||
| Q2 25 | — | $43.4M | ||
| Q1 25 | — | $14.8M | ||
| Q4 24 | $333.7M | $114.5M | ||
| Q3 24 | — | $237.0M | ||
| Q2 24 | — | $52.3M | ||
| Q1 24 | — | $123.2M |
自由现金流率DOCEPAM
| Q4 25 | 49.6% | 19.0% | ||
| Q3 25 | — | 20.5% | ||
| Q2 25 | — | 3.2% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | 47.8% | 9.2% | ||
| Q3 24 | — | 20.3% | ||
| Q2 24 | — | 4.6% | ||
| Q1 24 | — | 10.6% |
资本支出强度DOCEPAM
| Q4 25 | 124.4% | 1.1% | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | 105.6% | 1.3% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 0.6% |
现金转化率DOCEPAM
| Q4 25 | 10.99× | 2.59× | ||
| Q3 25 | — | 2.76× | ||
| Q2 25 | 11.48× | 0.60× | ||
| Q1 25 | 6.52× | 0.33× | ||
| Q4 24 | 235.43× | 1.26× | ||
| Q3 24 | 3.71× | 1.77× | ||
| Q2 24 | 2.17× | 0.58× | ||
| Q1 24 | 22.85× | 1.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
